Ethics of Non-Consensual Human Experimentation – NPR Sat, 20 Mar 2004 Below is a transcript of an NPR discussion about the ethics of a non-consensual artificial blood experiment. The discussion was slanted toward proceeding with highest risk non-consensual experimentation on the basis of unproven claims. The position taken by the…
Pfizer issues prosecutors a manual to defend drug – Star Ledger Thu, 5 Aug 2004 In the May 14, 2004, settlement of a lawsuit initiated by a whistleblower, Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. https://ahrp.org/infomail/04/05/16.php A report in The…
Dr. Carl Elliott's insightful essay in SLATE:: Why do drug companies want to give money to bioethicists in the first place? In the public relations business, this approach is called "third-party strategy."
Debate: Ethics of Surgically Implanting Drug Device in psychiatric patients Wed, 5 Nov 2003 An AHRP Infomail (October 7, 2003) criticizing the ethics of University of Pennsylvania’s planned surgical “drug implant” experiment in psychiatric patients, prompted a debate between AHRP president, Vera Sharav, and bioethicist, Paul Root Wolpe, Ph.D., University…
Comments submitted by The Alliance for Human Research Protection Re: Best Pharmaceuticals for Children’s Act of 2002 The National Academy of Sciences Committee of the Institute of Medicine on Clinical Research Involving Children August 18, 2003 Vera Hassner Sharav, President John H. Noble, Jr., Ph.D, Treasurer David Cohen, Ph.D, Secretary…
AHRP has been closely monitoring pediatric research trends since passage of the FDA Modernization Act of 1997. We believe that medications used in children should be thoroughly tested for safety, effectiveness and appropriate dose. But unlike adults who can exercise their autonomous right to informed consent, children who are enrolled in clinical trials are non-consensual human subjects. They should not, therefore, be made to assume the burden of testing possibly toxic drugs whose safety is unknown.
Infomail Archive 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 19, 2003: Eli Lilly Prozac UK Fact Sheet: “Not Recommended” for Children – PMDD Withdrawn in UK Dec 19, 2003: Not-So-Public-Relations: Drug Industry & Bioethics – is it casuistry or sophistry? Dec 18, 2003:…
Hopkins Asks Patients to Waive Privacy Rights to Facilitate Research Recruiting – AP/ ABC Tue, 8 Jul 2003 In the 19th century doctors robbed graves to obtain cadavers for medical training purposes. Today, medical researchers are far more ambitious– they seek backdoor access to living patients for medical experiments. A…
New AJOB InFocus article Examines Children in Clinical Research For immediate release May 7, 2003 (Philadelphia, PA) — The comprehensive study by Vera Hassner Sharav, President, The Alliance for Human Research Protection, examines a wide range of clinical research trials conducted on children and the ethical conflicts that arise from…
Infomail Archive – Pre 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav December 28, 2002: Will 2 to 5 year old Amer. kids be exposed to Smallpox Vaccine? Israeli Intelligence says “No immediate threat” December 24, 2002: Moral turpitude: Herpes experiment surpasses Tuskegee December 20,…
Patient vs. Portfolio: ImClone_Salon December 10, 2002. Salon.com looks at how conflicts of interest impact on patients who are recruited to serve as subjects of clinical drug trials. “Patients affected by the ImClone scandal have been lost in the media’s rush to cover the tale of Martha Stewart and other…
Patient vs. Portfolio: ImClone_Salon December 9, 2002 Salon.com looks at how conflicts of interest impact on patients who are recruited to serve as subjects of clinical drug trials. “Patients affected by the ImClone scandal have been lost in the media’s rush to cover the tale of Martha Stewart and other…
